Monet Howard

Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials

Philippe Gevaert, Theodore A. Omachi, Jonathan Corren et al. · Journal of Allergy and Clinical Immunology · 2020 · 697 citations · Full text

Medicine, Otolaryngology, Pharmacotherapy +17

Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies

Michael U. Callaghan, Claude Négrier, Ido Paz‐Priel et al. · Blood · 2020 · 289 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study

Philippe Gevaert, Rebecca Saenz, Jonathan Corren et al. · Journal of Allergy and Clinical Immunology · 2021 · 122 citations · Full text

Medicine, Otolaryngology, Pharmacotherapy +16

Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis

Toby M. Maher, Ulrich Costabel, Marilyn K. Glassberg et al. · European Respiratory Journal · 2020 · 76 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Low immunogenicity of emicizumab in persons with haemophilia A

Christophe Schmitt, Thomas Emrich, Sammy Chebon et al. · Haemophilia · 2021 · 56 citations · Full text

Medicine, Hematology, Pharmacotherapy +17